» Articles » PMID: 37781073

Tumor Suppressor LncRNA on Chromosome 8p12 (TSLNC8): A Concise Review in Human Malignancies

Overview
Journal J Cancer
Specialty Oncology
Date 2023 Oct 2
PMID 37781073
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor Suppressor Long Non-Coding RNA on Chromosome 8p12 (TSLNC8) is an RNA gene that generates a long non-coding RNA transcribed intergenically from both strands. Its significant role in human malignancies attracted significant attention in recent years. Expression analysis of TSLNC8 has been conducted in tissue specimens and cell lines using various techniques, including reverse transcription-quantitative polymerase chain reaction (RT-qPCR), hybridization (ISH), and microarray analysis. Furthermore, functional studies involving the loss and/or gain of TSLNC8 function in cellular and animal models have been carried out. These investigations have highlighted the impact of TSLNC8 on key tumor-related processes, including migration, invasion, and metastasis. Moreover, TSLNC8 has emerged as a regulator capable of modulating critical signaling pathways, such as the Hippo, STAT3, WNT/β-catenin, and MAPK pathways. In this review, we comprehensively synthesize the findings derived from and studies, along with analyses conducted on clinical samples, to provide a comprehensive understanding of the multifaceted role of TSLNC8 as a promising tumor biomarker and a potential target for therapeutic interventions.

Citing Articles

lncRNAs'p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer.

Shelash S, Shabeeb I, Ahmad I, Saleem H, Bansal P, Kumar A Med Oncol. 2024; 41(12):310.

PMID: 39516331 DOI: 10.1007/s12032-024-02536-w.


LINC00839 in Human Disorders: Insights into its Regulatory Roles and Clinical Impact, with a Special Focus on Cancer.

Hu Y, Hu Y, Lu X, Luo H, Chen Z J Cancer. 2024; 15(8):2179-2192.

PMID: 38495499 PMC: 10937278. DOI: 10.7150/jca.93820.


LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies.

Wang Y, Wang J, Zhang Y, Luo H, Yuan H J Cancer. 2024; 15(6):1498-1510.

PMID: 38370364 PMC: 10869981. DOI: 10.7150/jca.91984.


A concise review of the regulatory, diagnostic, and prognostic implications of HOXB-AS3 in tumors.

Wu H, Ye J, Zhang M, Luo H J Cancer. 2024; 15(3):714-728.

PMID: 38213732 PMC: 10777036. DOI: 10.7150/jca.91033.

References
1.
Xu J, Wang X, Zhu C, Wang K . A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. Front Cell Dev Biol. 2022; 10:997633. PMC: 9760833. DOI: 10.3389/fcell.2022.997633. View

2.
Mattick J, Amaral P, Carninci P, Carpenter S, Chang H, Chen L . Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023; 24(6):430-447. PMC: 10213152. DOI: 10.1038/s41580-022-00566-8. View

3.
Zhou S, Li H, Wang Z, Wang M, Li N, Wang Y . LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway. Cell Cycle. 2020; 19(21):2776-2792. PMC: 7714453. DOI: 10.1080/15384101.2020.1820697. View

4.
Panni S, Lovering R, Porras P, Orchard S . Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech. 2019; 1863(6):194417. DOI: 10.1016/j.bbagrm.2019.194417. View

5.
Zhang P, Wu W, Chen Q, Chen M . Non-Coding RNAs and their Integrated Networks. J Integr Bioinform. 2019; 16(3). PMC: 6798851. DOI: 10.1515/jib-2019-0027. View